HIV-1 and HIV-2 seroprevalence and risk factors among hospital outpatients in the Eastern Region of Ghana, West Africa.
Identifieur interne : 000713 ( PubMed/Checkpoint ); précédent : 000712; suivant : 000714HIV-1 and HIV-2 seroprevalence and risk factors among hospital outpatients in the Eastern Region of Ghana, West Africa.
Auteurs : Larry W. Chang [États-Unis] ; Muberak Osei-Kwasi ; Daniel Boakye ; Simeon Aidoo ; Angela Hagy ; James W. Curran ; Sten H. VermundSource :
- Journal of acquired immune deficiency syndromes (1999) [ 1525-4135 ] ; 2002.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Anticorps anti-VIH (sang), Facteurs de risque, Femelle, Ghana (épidémiologie), Humains, Hôpitaux, Infections à VIH (épidémiologie), Mâle, Patients en consultation externe, Séroprévalence du VIH, VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (immunologie), VIH-2 (Virus de l'Immunodéficience Humaine de type 2) (immunologie), Études séroépidémiologiques, Études transversales.
- MESH :
- immunologie : VIH-1 (Virus de l'Immunodéficience Humaine de type 1), VIH-2 (Virus de l'Immunodéficience Humaine de type 2).
- sang : Anticorps anti-VIH.
- épidémiologie : Ghana, Infections à VIH.
- Adolescent, Adulte, Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Hôpitaux, Mâle, Patients en consultation externe, Séroprévalence du VIH, Études séroépidémiologiques, Études transversales.
- Wicri :
- geographic : Ghana.
English descriptors
- KwdEn :
- MESH :
- chemical , blood : HIV Antibodies.
- geographic , epidemiology : Ghana.
- epidemiology : HIV Infections.
- immunology : HIV-1, HIV-2.
- Adolescent, Adult, Cross-Sectional Studies, Female, HIV Seroprevalence, Hospitals, Humans, Male, Middle Aged, Outpatients, Risk Factors, Seroepidemiologic Studies.
Abstract
A cross-sectional study of 854 outpatients seen at three hospitals in the Eastern Region of Ghana, West Africa assessed HIV-1 and HIV-2 seroprevalence rates and associated risk factors. During mid-1999, patients were tested in an anonymous study linked to a questionnaire and abstracted record data in three distinct communities with differing levels of urbanization. Combined HIV seroprevalence rates were 19.2% for Agomanya, the most rural community, 5.1% for Akwatia, and 3.4% for Nkawkaw, the most urbanized community. HIV-1 infection alone accounted for 84.5% of cases, compared with 9.5% and 6.0% for HIV-2 and dual infection, respectively. In a multivariable model, the Agomanya location was significantly associated with HIV status (odds ratio [OR], 7.7; 95% confidence interval [CI], 2.9-20.1; p <.0001). Employed people were also more likely to be infected (OR, 4.3; 95% CI, 1.02-18.3; p =.047). Among prenatal patients, those from Agomanya were more likely to report no live-in partner or spouse compared with Nkawkaw and Akwatia (p <.0001). These findings suggest sexual partner exchange patterns may be more useful in explaining HIV seroprevalence rates than level of community urbanization. Intervention programs directed at these high risk populations for HIV infection in Ghana are urgently needed.
PubMed: 11981368
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:11981368Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">HIV-1 and HIV-2 seroprevalence and risk factors among hospital outpatients in the Eastern Region of Ghana, West Africa.</title><author><name sortKey="Chang, Larry W" sort="Chang, Larry W" uniqKey="Chang L" first="Larry W" last="Chang">Larry W. Chang</name><affiliation wicri:level="2"><nlm:affiliation>Emory School of Medicine, Emory University, Atlanta, Georgia, U.S.A.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Emory School of Medicine, Emory University, Atlanta, Georgia</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Osei Kwasi, Muberak" sort="Osei Kwasi, Muberak" uniqKey="Osei Kwasi M" first="Muberak" last="Osei-Kwasi">Muberak Osei-Kwasi</name></author><author><name sortKey="Boakye, Daniel" sort="Boakye, Daniel" uniqKey="Boakye D" first="Daniel" last="Boakye">Daniel Boakye</name></author><author><name sortKey="Aidoo, Simeon" sort="Aidoo, Simeon" uniqKey="Aidoo S" first="Simeon" last="Aidoo">Simeon Aidoo</name></author><author><name sortKey="Hagy, Angela" sort="Hagy, Angela" uniqKey="Hagy A" first="Angela" last="Hagy">Angela Hagy</name></author><author><name sortKey="Curran, James W" sort="Curran, James W" uniqKey="Curran J" first="James W" last="Curran">James W. Curran</name></author><author><name sortKey="Vermund, Sten H" sort="Vermund, Sten H" uniqKey="Vermund S" first="Sten H" last="Vermund">Sten H. Vermund</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2002">2002</date><idno type="RBID">pubmed:11981368</idno><idno type="pmid">11981368</idno><idno type="wicri:Area/PubMed/Corpus">000321</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000321</idno><idno type="wicri:Area/PubMed/Curation">000321</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000321</idno><idno type="wicri:Area/PubMed/Checkpoint">000321</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000321</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">HIV-1 and HIV-2 seroprevalence and risk factors among hospital outpatients in the Eastern Region of Ghana, West Africa.</title><author><name sortKey="Chang, Larry W" sort="Chang, Larry W" uniqKey="Chang L" first="Larry W" last="Chang">Larry W. Chang</name><affiliation wicri:level="2"><nlm:affiliation>Emory School of Medicine, Emory University, Atlanta, Georgia, U.S.A.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Emory School of Medicine, Emory University, Atlanta, Georgia</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Osei Kwasi, Muberak" sort="Osei Kwasi, Muberak" uniqKey="Osei Kwasi M" first="Muberak" last="Osei-Kwasi">Muberak Osei-Kwasi</name></author><author><name sortKey="Boakye, Daniel" sort="Boakye, Daniel" uniqKey="Boakye D" first="Daniel" last="Boakye">Daniel Boakye</name></author><author><name sortKey="Aidoo, Simeon" sort="Aidoo, Simeon" uniqKey="Aidoo S" first="Simeon" last="Aidoo">Simeon Aidoo</name></author><author><name sortKey="Hagy, Angela" sort="Hagy, Angela" uniqKey="Hagy A" first="Angela" last="Hagy">Angela Hagy</name></author><author><name sortKey="Curran, James W" sort="Curran, James W" uniqKey="Curran J" first="James W" last="Curran">James W. Curran</name></author><author><name sortKey="Vermund, Sten H" sort="Vermund, Sten H" uniqKey="Vermund S" first="Sten H" last="Vermund">Sten H. Vermund</name></author></analytic><series><title level="j">Journal of acquired immune deficiency syndromes (1999)</title><idno type="ISSN">1525-4135</idno><imprint><date when="2002" type="published">2002</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Cross-Sectional Studies</term><term>Female</term><term>Ghana (epidemiology)</term><term>HIV Antibodies (blood)</term><term>HIV Infections (epidemiology)</term><term>HIV Seroprevalence</term><term>HIV-1 (immunology)</term><term>HIV-2 (immunology)</term><term>Hospitals</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Outpatients</term><term>Risk Factors</term><term>Seroepidemiologic Studies</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anticorps anti-VIH (sang)</term><term>Facteurs de risque</term><term>Femelle</term><term>Ghana (épidémiologie)</term><term>Humains</term><term>Hôpitaux</term><term>Infections à VIH (épidémiologie)</term><term>Mâle</term><term>Patients en consultation externe</term><term>Séroprévalence du VIH</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (immunologie)</term><term>VIH-2 (Virus de l'Immunodéficience Humaine de type 2) (immunologie)</term><term>Études séroépidémiologiques</term><term>Études transversales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>HIV Antibodies</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ghana</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term><term>VIH-2 (Virus de l'Immunodéficience Humaine de type 2)</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HIV-1</term><term>HIV-2</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps anti-VIH</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ghana</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Cross-Sectional Studies</term><term>Female</term><term>HIV Seroprevalence</term><term>Hospitals</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Outpatients</term><term>Risk Factors</term><term>Seroepidemiologic Studies</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Hôpitaux</term><term>Mâle</term><term>Patients en consultation externe</term><term>Séroprévalence du VIH</term><term>Études séroépidémiologiques</term><term>Études transversales</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A cross-sectional study of 854 outpatients seen at three hospitals in the Eastern Region of Ghana, West Africa assessed HIV-1 and HIV-2 seroprevalence rates and associated risk factors. During mid-1999, patients were tested in an anonymous study linked to a questionnaire and abstracted record data in three distinct communities with differing levels of urbanization. Combined HIV seroprevalence rates were 19.2% for Agomanya, the most rural community, 5.1% for Akwatia, and 3.4% for Nkawkaw, the most urbanized community. HIV-1 infection alone accounted for 84.5% of cases, compared with 9.5% and 6.0% for HIV-2 and dual infection, respectively. In a multivariable model, the Agomanya location was significantly associated with HIV status (odds ratio [OR], 7.7; 95% confidence interval [CI], 2.9-20.1; p <.0001). Employed people were also more likely to be infected (OR, 4.3; 95% CI, 1.02-18.3; p =.047). Among prenatal patients, those from Agomanya were more likely to report no live-in partner or spouse compared with Nkawkaw and Akwatia (p <.0001). These findings suggest sexual partner exchange patterns may be more useful in explaining HIV seroprevalence rates than level of community urbanization. Intervention programs directed at these high risk populations for HIV infection in Ghana are urgently needed.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11981368</PMID><DateCreated><Year>2002</Year><Month>04</Month><Day>30</Day></DateCreated><DateCompleted><Year>2002</Year><Month>05</Month><Day>16</Day></DateCompleted><DateRevised><Year>2007</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1525-4135</ISSN><JournalIssue CitedMedium="Print"><Volume>29</Volume><Issue>5</Issue><PubDate><Year>2002</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of acquired immune deficiency syndromes (1999)</Title><ISOAbbreviation>J. Acquir. Immune Defic. Syndr.</ISOAbbreviation></Journal><ArticleTitle>HIV-1 and HIV-2 seroprevalence and risk factors among hospital outpatients in the Eastern Region of Ghana, West Africa.</ArticleTitle><Pagination><MedlinePgn>511-6</MedlinePgn></Pagination><Abstract><AbstractText>A cross-sectional study of 854 outpatients seen at three hospitals in the Eastern Region of Ghana, West Africa assessed HIV-1 and HIV-2 seroprevalence rates and associated risk factors. During mid-1999, patients were tested in an anonymous study linked to a questionnaire and abstracted record data in three distinct communities with differing levels of urbanization. Combined HIV seroprevalence rates were 19.2% for Agomanya, the most rural community, 5.1% for Akwatia, and 3.4% for Nkawkaw, the most urbanized community. HIV-1 infection alone accounted for 84.5% of cases, compared with 9.5% and 6.0% for HIV-2 and dual infection, respectively. In a multivariable model, the Agomanya location was significantly associated with HIV status (odds ratio [OR], 7.7; 95% confidence interval [CI], 2.9-20.1; p <.0001). Employed people were also more likely to be infected (OR, 4.3; 95% CI, 1.02-18.3; p =.047). Among prenatal patients, those from Agomanya were more likely to report no live-in partner or spouse compared with Nkawkaw and Akwatia (p <.0001). These findings suggest sexual partner exchange patterns may be more useful in explaining HIV seroprevalence rates than level of community urbanization. Intervention programs directed at these high risk populations for HIV infection in Ghana are urgently needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Larry W</ForeName><Initials>LW</Initials><AffiliationInfo><Affiliation>Emory School of Medicine, Emory University, Atlanta, Georgia, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osei-Kwasi</LastName><ForeName>Muberak</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Boakye</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Aidoo</LastName><ForeName>Simeon</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Hagy</LastName><ForeName>Angela</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Curran</LastName><ForeName>James W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Vermund</LastName><ForeName>Sten H</ForeName><Initials>SH</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AI 27767</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Acquir Immune Defic Syndr</MedlineTA><NlmUniqueID>100892005</NlmUniqueID><ISSNLinking>1525-4135</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015483">HIV Antibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015483" MajorTopicYN="N">HIV Antibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015528" MajorTopicYN="Y">HIV Seroprevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015498" MajorTopicYN="N">HIV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010045" MajorTopicYN="N">Outpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>5</Month><Day>1</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>5</Month><Day>17</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>5</Month><Day>1</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11981368</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Géorgie (États-Unis)</li></region></list><tree><noCountry><name sortKey="Aidoo, Simeon" sort="Aidoo, Simeon" uniqKey="Aidoo S" first="Simeon" last="Aidoo">Simeon Aidoo</name><name sortKey="Boakye, Daniel" sort="Boakye, Daniel" uniqKey="Boakye D" first="Daniel" last="Boakye">Daniel Boakye</name><name sortKey="Curran, James W" sort="Curran, James W" uniqKey="Curran J" first="James W" last="Curran">James W. Curran</name><name sortKey="Hagy, Angela" sort="Hagy, Angela" uniqKey="Hagy A" first="Angela" last="Hagy">Angela Hagy</name><name sortKey="Osei Kwasi, Muberak" sort="Osei Kwasi, Muberak" uniqKey="Osei Kwasi M" first="Muberak" last="Osei-Kwasi">Muberak Osei-Kwasi</name><name sortKey="Vermund, Sten H" sort="Vermund, Sten H" uniqKey="Vermund S" first="Sten H" last="Vermund">Sten H. Vermund</name></noCountry><country name="États-Unis"><region name="Géorgie (États-Unis)"><name sortKey="Chang, Larry W" sort="Chang, Larry W" uniqKey="Chang L" first="Larry W" last="Chang">Larry W. Chang</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000713 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000713 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:11981368
|texte= HIV-1 and HIV-2 seroprevalence and risk factors among hospital outpatients in the Eastern Region of Ghana, West Africa.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:11981368" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |